Bio-Tech Company Syner-G and Software Company xSuite to Relocate

BOSTON, March 7, 2023 – JLL announced today that Syner-G Biopharma Group and software company xSuite signed leases to relocate to 100 Pennsylvania Ave, a 74,000 square feet Class A building owned by CB Equities in Framingham, MA. Syner-G will lease 7,691 square feet of space, and xSuite will lease a 3,708 square feet spec office suite, one of the move-in-ready office spaces in the building that will soon feature a Club Room, a renovated lobby and other common areas, and more.

“From easier permitting processes to the potential for flexible leases, more tenants are seeking the benefits of move-in-ready office spaces with premier amenities,” said Alison Powers, Executive Vice President at JLL. “Syner-G and xSuites move to 100 Pennsylvania Ave. highlights just that – a move into a modern build-out delivered quickly that meets the needs of employees today while benefiting both landlords and tenants alike.”

In a prime central location with high visibility directly off Route 9 and less than a 1/4 mile to the Mass Pike exit 12, 100 Pennsylvania Avenue will feature a renovated lobby and common areas, including a “Club Room” equipped with beer, wine, Starbucks coffee and other high-quality, first-class amenities complete with new outdoor patio space. CB Equities is continuing to build modern-built spec office suites for quick delivery. The building has additional space available to accommodate tenants from 4,000 to 16,000 square feet in size.

"With a growing demand for not only move-in ready premier office spaces but high-end improvements and amenities that meet tenants' needs today, 100 Pennsylvania Ave is strategically positioned to deliver that," said Colin Gillespie at CB Equities. "From a renovated lobby and common areas to the Club Room and newly designed office spaces, the building truly encompasses what Class A means today – and we're excited to share that with Syner-G, xSuite, and future tenants."

The JLL team representing CB Equities is comprised of Executive Vice President Alison Powers, Managing Director Bob McGuire. Managing Director Alex Dauria and Executive Vice President Sam Crossan represented Syner-G Biopharma. Representing xSuites is Kelleher & Sadowsky Executive Vice President Philip DeSimone and Associate Ross Miner.